{
  "docId": "019de070-7c63-7128-8a46-f79d73ca634e",
  "docSlug": "e7a5d9b34e946c6ef888782967ccb8f4",
  "documentTitle": "AbCellera | IPO Presentation Deck | 38 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 38,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "Uses a chevron-style layout to transition from the problem statement to the supporting metrics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-7c63-7128-8a46-f79d73ca634e/5",
  "deckHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e",
  "deckJsonHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e.json",
  "deckAnchorHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.67,
        "y": 0.65
      },
      "kind": "metric",
      "text": "~9.4 to 12 years",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12885a19-d47e-4e11-8766-db82007f6456",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.53,
        "y": 0.65
      },
      "kind": "metric",
      "text": "~$3 billion",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3dfd4de-a7ab-450f-88d6-e11b927e2410",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.12,
        "x": 0.82,
        "y": 0.62
      },
      "kind": "metric",
      "text": "~90% failure rate",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e42746a5-18f5-47d9-9419-90c664ce494b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.1,
        "y": 0.68
      },
      "kind": "paragraph",
      "text": "Drug developers focus on getting one drug candidate to the finish line. The result is a chronic underinvestment in the technologies to make the process of drug development better.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "417847a8-f251-4ae6-a98b-d02ac714f0ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.53,
        "y": 0.25
      },
      "kind": "title",
      "text": "Drug development fails too often, takes too long and costs too much.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "387f2f33-d514-47af-a297-07383d31b2c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.1,
        "y": 0.28
      },
      "kind": "title",
      "text": "THE PROBLEM",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5bf9094a-967a-4c97-99ff-f44d225dd718",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.1,
        "y": 0.035
      },
      "kind": "title",
      "text": "LIMITED TECH & LIMITED ACCESS LIMITS IMPACT",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "908a8113-d744-42ee-aca5-6092560d5f14",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "e8dd4137-7498-464c-9673-5907a50aa35c",
      "evidence": "The slide presents a clear problem statement with a specific issue, metrics, and a headline.",
      "confidence": 0.7
    },
    {
      "name": "Three-Act Structure",
      "slug": "three-act-structure",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "96e8f20a-797d-4f25-989d-1bd7bd186d2b",
      "evidence": "The slide sets up the problem, which is a common starting point for a three-act structure.",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "c088043c-3ced-4148-ba22-456efd1500c7",
      "evidence": "Frames the current state of drug development as a failure-prone process to justify the need for the company's solution.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "bbe24364-85c5-4f34-b346-d5a488908a95",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slides 5-6 present the problem statement and market sizing",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5ab65160-9f66-4d29-b690-0ae15cba8c59",
      "evidence": "Slides 5-6 present the limitations of current technology",
      "position": 0,
      "objective": "What is the cost of not adopting new technology for antibody discovery?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 38,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0790a1a3-4790-4249-807c-1b7d69510973",
      "evidence": "The deck presents a clear 'why' for AbCellera's technology throughout",
      "position": 1,
      "objective": "Why is AbCellera's technology the right solution for antibody discovery?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}